Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Common Equity (2016 - 2025)

MedWellAI (MWAI) has disclosed Common Equity for 10 consecutive years, with -$7.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity fell 43.19% to -$7.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.5 million, a 43.19% decrease, with the full-year FY2025 number at -$6.6 million, down 71.38% from a year prior.
  • Common Equity was -$7.5 million for Q4 2025 at MedWellAI, down from -$7.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $11.5 million in Q4 2021 to a low of -$7.5 million in Q4 2025.
  • A 5-year average of $1.7 million and a median of -$980040.0 in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 22176.0% in 2021, then tumbled 658.11% in 2024.
  • MedWellAI's Common Equity stood at $11.5 million in 2021, then decreased by 24.81% to $8.6 million in 2022, then plummeted by 119.84% to -$1.7 million in 2023, then tumbled by 204.73% to -$5.2 million in 2024, then crashed by 43.19% to -$7.5 million in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Common Equity are -$7.5 million (Q4 2025), -$7.1 million (Q3 2025), and -$6.6 million (Q2 2025).